Hamilton Lane (HLNE)
(Real Time Quote from BATS)
$141.69 USD
+1.80 (1.29%)
Updated Jul 22, 2024 01:12 PM ET
1-Strong Buy of 5 1
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
HLNE 141.69 +1.80(1.29%)
Will HLNE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HLNE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HLNE
Decent Equity Market to Aid T. Rowe Price (TROW) in Q2 Earnings
Will Lower Market Volatility Hurt Franklin's (BEN) Q3 Earnings?
HLNE: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for Principal Financial (PFG) in Q2 Earnings?
Are You Looking for a Top Momentum Pick? Why Hamilton Lane (HLNE) is a Great Choice
The Zacks Analyst Blog Highlights Hancock Whitney, UnitedHealth, Eni S.p.A, FedEx and Hamilton Lane
Other News for HLNE
Avista Capital, Hamilton Lane announce partnership in Cosette Pharmaceuticals
Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals
Avista Capital, Hamilton Lane announce partnership in Cosette Pharmaceuticals
Hamilton Lane Incorporated to Announce First Quarter Fiscal 2025 Results on August 6, 2024
Canoe Intelligence Raises $36 Million Series C Funding Led by Goldman Sachs to Further Market Expansion